Peter Asaga Mac | Infectious diseases | Best Researcher Award

Dr. Peter Asaga Mac | Infectious diseases | Best Researcher Award 

Senior clinical research fellow | University Hospital Freiburg | Germany

Dr. Peter Asaga Mac is a dedicated researcher at Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany, specializing in infectious and zoonotic diseases. His scientific work focuses on understanding the epidemiology, immune response, and transmission dynamics of emerging viral infections, particularly mosquito-borne diseases such as Chikungunya and Dengue. Through a combination of field-based studies, serological analyses, and molecular surveillance, Dr. Mac investigates how co-circulating arboviruses interact within populations and contribute to public health challenges in endemic regions, especially in Africa. His notable publication, “An Undetected Expansion, Spread, and Burden of Chikungunya and Dengue Cocirculating Antibodies in Nigeria” (Zoonotic Diseases, 2024), provides valuable insight into the unnoticed expansion of these viruses and their long-term implications for disease control strategies. Dr. Mac’s research is characterized by its translational value—bridging scientific discovery with actionable health interventions to improve epidemic preparedness and response. His collaborations with international scientists strengthen global efforts to monitor zoonotic threats and develop more resilient surveillance systems. Despite being an early-career researcher, his contributions are gaining recognition within the academic community. With 3 publications, 14 citations  and an h-index of 2, Dr. Mac’s growing academic footprint reflects his potential to make lasting contributions to infectious disease research, particularly in the areas of viral immunology, epidemiological modeling, and global health resilience. His commitment to evidence-based solutions continues to shape a better understanding of emerging diseases and their impact on human health worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Chackalackal, D. J., Al-Aghbari, A. A. A., Jang, S. Y., Ramirez, T. R., Vincent, J., Joshi, A., et al. (2021). The Covid-19 pandemic in low- and middle-income countries: Who carries the burden? Review of mass media and publications from six countries. Pathogens and Global Health, 115(3), 178–187.
Cited by: 49

2. Mac, P. A., Suleiman, A. C., & Airiohuodion, P. E. (2019). High prevalence of hepatitis B virus infection among pregnant women attending antenatal care in Central Nigeria. Journal of Infectious Diseases and Epidemiology, 5(1), 068.
Cited by: 34

3. Mac, P. A., Asheadzi, H. F., Gideon, A., Thaker, P., & Airiohuodion, P. (2019). Prevalence of Plasmodium falciparum among Nigerians in Abuja and Central States: A comparative analysis of sensitivity and specificity using rapid diagnostic test and microscopy. International Journal of Tropical Diseases, 1, 014.
Cited by: 22

4. Mac, P. A., Kroeger, A., & Airiohuodion, P. E. (2019). Needs assessment of emergency medical and rescue services in Abuja/Nigeria and environs. BMC Emergency Medicine, 19(78), 8.
Cited by: 21

5. Mac, P. A., Airiohuodion, P. E., Yako, A. B., et al. (2022). The seroprevalence and hidden burden of chikungunya endemicity and malaria mono- and coinfection in Nigeria. International Journal of Environmental Research and Public Health, 19(15), 8896.
Cited by: 19

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.